Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year
BiotechTV - News
00:00
Non-obstructive HCM trial design
Salim highlights the smart dual-primary design for non-obstructive HCM and expects readout in early Q2.
Play episode from 14:33
Transcript
